Many small businesses in Minneapolis are struggling in the wake of increased federal immigration enforcement in the city and, of course, protests for weeks. Business owners say that ever since Operation Metro Surge began in December. Many workers are scared to go to their jobs and fewer people are out shopping.MSNOW reporter Nandi Iguwanu spoke to some of those Minneapolis business owners today. Watch this. We haven't been open or it's just been a ton of fear for just us and our employees.And apart from, ou ...

NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ardent Health, Inc. ("Ardent Health, Inc." or the "Company") (NYSE: ARDT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ardent Health, Inc. investors who were adversely affected by alleged securities fraud between July 18, 2024 and November 12, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/ar ...

Core Viewpoint - Hagens Berman is investigating Ardent Health, Inc. for allegedly misleading investors regarding its revenue recognition systems and professional liability reserves, leading to significant financial repercussions and a class action lawsuit [2][4]. Group 1: Allegations and Financial Impact - Ardent Health reportedly assured investors of using "detailed reviews of historical collections" for valuing receivables, but later admitted to employing a "180-day cliff" for reserves, which contributed to a 33% stock collapse [2][5]. - The company experienced a $54 million increase in professional liability reserves due to settlements and ongoing litigation, alongside a $42.6 million revenue reduction attributed to a new accounting method for estimating receivables [5]. - Following the disclosures on November 12, 2025, Ardent's stock price fell nearly 34%, indicating a severe market reaction to the revelations [5]. Group 2: Legal Proceedings and Next Steps - A lead plaintiff deadline for the pending securities class action is set for March 9, 2026, with Hagens Berman actively advising investors who purchased shares between July 18, 2024, and November 12, 2025 [4][5]. - The lawsuit claims that Ardent's financial health was misrepresented, suggesting that the company's monitoring of receivables was a facade for a mechanical write-off system [3][4].

Earnings Season Overview - The fourth-quarter earnings season has begun with 106 S&P 500 companies reporting results, showing 76.4% beating EPS estimates and 63.2% surpassing revenue estimates, indicating an improving earnings outlook [1][7]. Investor Sentiment - Investors are optimistic about maintaining momentum throughout the earnings season, as companies reporting better-than-expected earnings typically see an increase in stock prices, alongside easing inflation being a positive factor [2]. Stock Selection Strategy - Investors are encouraged to select stocks based on broker recommendations and upward revisions in earnings estimates, with a focus on stocks like Cardinal Health (CAH), AutoNation (AN), Target Corporation (TGT), Avnet (AVT), and ABM Industries (ABM) for potential returns [3][7]. Screening Criteria - A screening process has been established to identify stocks with improving broker recommendations and earnings estimate revisions, incorporating price/sales ratios as a valuation metric [4][5]. Stock Highlights - Cardinal Health is projected to have a 16.3% year-over-year revenue improvement for fiscal 2026 and has a long-term earnings growth rate of 14.7% [7]. - AutoNation is expanding its dealer network and enhancing digital capabilities, with a 0.3% upward revision in earnings estimates for 2026 [8][9]. - Target is undergoing a transformation with a focus on design-led merchandising and advanced analytics for better demand forecasting [10][11]. - Avnet is benefiting from strong defense and data center markets, with a focus on Internet of Things capabilities [12][13]. - ABM Industries is enhancing its position in the data center market through acquisitions and has seen a 2.2% upward revision in earnings estimates for the current year [13][14].

Core Viewpoint - RBC Capital has raised the price target for HCA Healthcare to $555 from $525 while maintaining an Outperform rating on the shares, indicating positive sentiment towards the company's performance and future outlook [1]. Financial Performance - HCA Healthcare's Q4 results were strong, leading to a favorable reaction in the stock price [1]. - The 2026 full-year outlook is better than expected, reflecting improved core performance [1]. Cost Savings - The company is expected to achieve $400 million in savings from resiliency efforts, which will more than offset the expiration of the ePTC and the lower contribution from state supplemental programs [1].

NEW YORK, Jan. 29, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ardent Health, Inc. (NYSE: ARDT). Shareholders who purchased shares of ARDT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/ardent-health-inc-loss-submission-form/?id=183282&from=4 CLASS PERIOD: July 18, 202 ...

Summary of Key Points from the Conference Call Industry Overview - **China Equity Strategy**: The 2026 JPM China Opportunity Forum highlighted a constructive outlook on China equities, emphasizing thematic trades such as leading exporters, beneficiaries of AI infrastructure capital expenditure, anti-involution strategies, K-shaped consumption recovery, and property market upside optionality [2][7]. Core Insights - **AI Ecosystem**: The memory and ESS (Energy Storage Systems) sectors are benefiting from global AI capital expenditure demand. Notable trends include a memory up-cycle and rising localization. However, consumer electronics and automotive sectors are facing component cost increases and lower trade-in subsidies year-on-year [6][14]. - **Anti-involution Strategies**: Companies like H World and Atour are shifting to rational pricing strategies to enhance market share. Home appliance brands are focusing on innovation rather than price cuts. The solar industry is also expected to see continued anti-involution efforts [6][31]. - **Consumption Trends**: Leading brands are innovating and optimizing to counteract soft domestic demand, with a focus on overseas growth. The "Liberation Day" in April 2025 is noted as a potential trigger for a future recovery in consumer confidence [6][29]. - **Healthcare Sector**: Drug innovation is a key growth driver for pharmaceutical companies, with a focus on launching new drugs and expanding into overseas markets. Healthcare service providers are gradually recovering, aided by technology upgrades [35][38]. - **Humanoid Robots**: China leads in global humanoid robot shipments, driven by government orders. The sector faces challenges in commercialization and scalability, but industrial applications are expected to show strong potential [40][41]. Important Data Points - **Smartphone Market**: Global smartphone shipments are expected to decline by 0.9% in 2026, with iPhones projected to outperform Android devices. JPM forecasts iPhone EMS builds at 251 million units for 2025, a 6% year-on-year increase [14][15]. - **Automotive Sales**: A slow start for passenger vehicle sales in 2026 is anticipated, with a forecasted decline of 24-29% quarter-on-quarter in Q1 2026 [15]. - **Energy Storage Systems**: Global ESS battery shipments are projected to grow over 40% to approximately 900 GWh in 2026, driven by policy momentum in China and strong orders from Europe [19]. - **Semiconductor Market**: The semiconductor industry is expected to see divergent dynamics, with consumer electronics facing softness while memory and foundry segments show strength. Average DRAM pricing is forecasted to increase by approximately 60% year-on-year in 2026 [20][21]. Company-Specific Insights - **Top Picks**: J.P. Morgan's preferred companies include Zhongji Innolight, NAURA, and CATL, among others, with various ratings and market caps provided [8][10][11][13]. - **Healthcare Innovations**: Companies like Hansoh are targeting over 80% of revenue from innovative medicines by FY25, with a robust pipeline in oncology and diabetes [35][37]. Additional Considerations - **Cost Management**: Companies are overcoming upward cost pressures through process optimization and effective cost pass-through strategies in export markets [34]. - **Global Expansion**: Chinese brands are increasingly building capacity and expanding distribution in emerging markets, with notable investments in ASEAN production bases [33]. This summary encapsulates the key insights and data points from the conference call, providing a comprehensive overview of the current landscape and future outlook for various sectors within the Chinese market.

Group 1 - Dalian is implementing a pilot service for "no accompanying care" in major hospitals to alleviate the burden on patients' families and enhance the medical environment [1] - The city will expand the "no accompanying care" service model to all tertiary public hospitals, optimizing service processes and providing professional care throughout the patient's stay [1] - Starting January 1, 2026, Dalian will increase the maximum housing provident fund loan limits to 600,000 yuan for individuals and 1 million yuan for couples, supporting housing demand and promoting a stable real estate market [1] Group 2 - The housing provident fund policies will be enhanced for specific groups, including an increase of 200,000 yuan for undergraduate graduates and 400,000 yuan for master's graduates, with even higher limits for doctoral graduates and high-level talents [2] - Dalian's Sports Bureau plans to enrich the year-round fitness event system, focusing on major events like the Dalian International Walking Conference and community sports activities to promote fitness and community engagement [2]

Core Viewpoint - A securities class action lawsuit has been filed against Ardent Health, Inc. following its poor Q3 2025 financial results, alleging misleading statements regarding revenue recognition and liability reserves [1][2]. Company Allegations - The lawsuit claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves, urging affected investors to come forward [2][4]. - The complaint states that Ardent assured investors of an active monitoring process for accounts receivable, which was misleading as the company primarily used a 180-day cliff for reserving accounts [4][5]. Financial Impact - On November 12, 2025, Ardent disclosed a transition to a new accounting method that resulted in a revenue reduction of $42.6 million due to hindsight evaluations [5][6]. - The company's CFO indicated that the new accounting system recognized reserves earlier in an account's life cycle, contrasting previous assurances [6]. - Additionally, Ardent reported a $47.2 million increase in professional liability reserves, contributing to a rise in total operating expenses as a percentage of total revenue [6]. Market Reaction - Following the announcement of the financial results and the new accounting method, Ardent's share price fell by $4.75, a decrease of 33% [6]. Investigation and Whistleblower Information - Hagens Berman is investigating whether Ardent was aware of issues with its revenue accounting system that concealed payor denials [7]. - Whistleblowers with non-public information regarding Ardent Health are encouraged to assist in the investigation, with potential rewards under the SEC Whistleblower program [8].

（来源：新华日报） □ 本报记者 安莹 杨彦 王甜 蒋明睿 2026年，是"十五五"规划的开局之年，也是江苏卫生健康事业迈向更高水平的关键一年。 江苏卫生健康系统深入贯彻党的二十届四中全会部署和省委十四届十次全会精神，总结2025年工作成 效，科学谋划"十五五"改革发展新路径，精准对接人民健康新需求，记者采访了全省13个设区市的卫生 健康委员会主任，回顾2025，畅想2026。透过各地的实践与展望，江苏正努力让每一位百姓的健康获得 感更有成色、幸福感更可持续、安全感更有保障。 南 京 2025年，南京成功入选中央财政支持的公立医院改革与高质量发展示范项目；改革示范效应凸显；医防 融合成效显著；基层网底不断夯实；医疗服务能级跃升，南京市儿童医院顺利申报国家区域医疗中心； 普惠托育加快发展；科技创新再攀高峰。 南京市卫生健康委主任唐伯才表示，推动卫生健康事业与人口发展双向提质，首先要以规划为引领。贯 彻新发展理念，将人均预期寿命、母婴安全水平、传染病与慢性病防控、普惠托育服务发展等纳入规划 核心指标。紧扣新质生产力发展要求，推动生物医药产业创新突破，促进"AI+医疗健康"深度融合。 其次，要以改革为动力，打造长三 ...